Abstract |
The effects of 3-[2-[4-(2-methylphenyl)-1- piperazinyl]ethyl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a] pyridine HCl ( dapiprazole), a new drug with alpha- adrenergic blocking properties, on pupillary diameter and intraocular pressure have been studied in rabbits. Following i.v. administration, a reduction of intraocular pressure is observed at doses devoid of activity on pupillary diameter. Following topical application, a miotic and ocular hypertensive action was observed at the same doses; the hypotensive action is produced in both normal rabbits and in rabbits with water load- or corticosteroid-induced ocular hypertension. Contact lenses increase the duration of effects of dapiprazole. These results suggest a potential interest of dapiprazole in glaucoma, with particular reference to the topical treatment of angle-closure glaucoma.
|
Authors | B Silvestrini, L Bonomi, R Lisciani, S Perfetti, R Belluci, F Massa, A Baldini |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 32
Issue 6
Pg. 678-81
( 1982)
ISSN: 0004-4172 [Print] Germany |
PMID | 6126199
(Publication Type: Journal Article)
|
Chemical References |
- Adrenal Cortex Hormones
- Antipsychotic Agents
- Piperazines
- Triazoles
- Water
- dapiprazole
- Clonidine
|
Topics |
- Administration, Topical
- Adrenal Cortex Hormones
(pharmacology)
- Animals
- Antipsychotic Agents
(pharmacology)
- Clonidine
(pharmacology)
- Drug Interactions
- Female
- Injections, Intravenous
- Intraocular Pressure
(drug effects)
- Male
- Piperazines
- Pupil
(drug effects)
- Rabbits
- Triazoles
(pharmacology)
- Water
(pharmacology)
|